investigated that ALDH1A1‐expressing breast cancers are shown to be more likely negative for ER and progesterone receptor (PR) expression, but positive for epidermal growth factor receptor 2 (HER2) and Ki‐67, correlating with more aggressive breast cancer subtypes.108. The gene discussed is ERBB2; the disease is breast carcinoma.